Home » Topics » BioWorld Science

BioWorld Science
RSS

Lankenau Institute for Medical Research patents anti-rabies antibodies

Dec. 24, 2019

Ubrogepant approved by the FDA for migraine

Dec. 24, 2019

ABL Bio describes new anti-B7-H3 antibodies

Dec. 24, 2019

FDA approves first trial of ST-001 nanoFenretinide in T-cell non-Hodgkin's lymphoma

Dec. 24, 2019

CAPELLA trial recruits patients with HIV to evaluate add-on lenacapavir treatment

Dec. 24, 2019

Celgene presents results from two phase I studies of CC-90002

Dec. 24, 2019

Phase I study of mutant EGFR inhibitor TQB-3804 begins

Dec. 24, 2019

PET imaging agent PyL meets primary endpoint in phase III prostate cancer trial

Dec. 24, 2019

Phase II study begins for URO-902 in overactive bladder

Dec. 24, 2019

Trial to evaluate Trevena's TRV-734 for opioid use disorder

Dec. 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...